have a hysterectomy for benign conditions.' He would be told that though only a few of these detectable thrombi will ever produce pulmonary embolism a fatal embolus can occur in any patient with deep-vein thrombosis, especially when the thrombus is in the proximal iliofemoral segments.2 So the chain of reasoning put to him would be that operation increases his chance of developing leg-vein thrombosis, which in turn increases his chance of pulmonary embolism, which in turn decreases his chance of survival. Effective prophylaxis should minimise all the steps in the chain-but the only one which is of interest to the patient is the final one: his chance of dying of pulmonary embolism. All the other steps, crucial though they may appear to his attendants, are merely means to this end and are not an end in themselves.
thrombi can be found in 7000 of elderly patients operated on for hip fractures, 500 / of patients who undergo hip replacement, 50% of patients after prostatectomy, 3500 of general surgical patients over the age of 40, and 15% of women who have a hysterectomy for benign conditions.' He would be told that though only a few of these detectable thrombi will ever produce pulmonary embolism a fatal embolus can occur in any patient with deep-vein thrombosis, especially when the thrombus is in the proximal iliofemoral segments.2 So the chain of reasoning put to him would be that operation increases his chance of developing leg-vein thrombosis, which in turn increases his chance of pulmonary embolism, which in turn decreases his chance of survival. Effective prophylaxis should minimise all the steps in the chain-but the only one which is of interest to the patient is the final one: his chance of dying of pulmonary embolism. All the other steps, crucial though they may appear to his attendants, are merely means to this end and are not an end in themselves.
The shrewd question which the patient would therefore put to his doctors would be, "If fatal pulmonary embolism is common after operation then it should have been easy to show that your treatments are really effective because they will have kept more people alive. Have Town group allow us to draw conclusions about infrequent events such as pulmonary emboli with the same degree of confidence with which we can form a view about the more frequent calf-vein lesions ? All concerned will urge that this study should not be stopped before it produces convincing results.
Even when we have eventually clarified the place of low-dose heparin in general surgical patients, this cannot be a universal panacea; its mode of action is to prevent operative trauma from activating the clotting mechanism and it therefore functions best when given before the trauma. In patients with fractures the first dose can only follow the trauma, when activation has already occurred. In the highest-risk patients of all, elderly patients with femoral neck fractures, low-dose heparin does not significantly reduce the frequency of isotopically detected venous thrombosis."7 Patients undergoing total hip replacement are a specially crucial group. They are at high risk because of the direct trauma to the femoral vein19 and yet are so highly selected for their fitness in other respects that death from pulmonary embolism would be untimely. The evidence on the effect of low-dose heparin on intermediate end points is confiicting20-22 and there is no evidence that it alters mortality.
To our questioning patient, therefore, we would have to say that conventional anticoagulation remains the only regimen for which a significant effect on total mortality has been claimed, but that it can never make a contribution to large-scale prophylaxis because of the problems of control, dosage, and acceptance by surgeons. In respect of low-dose heparin we can only echo Sherry23 and say, "One is forced to the conclusion that there is a very high probability that the difference in fatal pulmonary embolism between the two groups is real," but that because of the premature cessation of the international trial and the failure of any other group to mount a similar, large-scale trial we are left with a probability, and not a certainty. Thus 
